I don’t want to shake your confidence Harry, but I think you’re confusing the distinction between the tetanus vaccine and tetanus antiserum.
Tetanus vaccine (as contained in the DTP vaccine) contains inactivated tetanus toxin (termed a toxoid), and it does stimulate an active immune response, resulting in antibody production. The antibodies are directed against the toxin and are protective because they bind to the toxin, preventing it from exerting its toxic effects. More importantly, though, is that stimulation by the toxoid results in the formation of “memory” lymphocytes that can quickly re-initiate antibody production should the need arise. The problem with this system is that the protection conferred by the vaccine does wear off with time, hence the need for “boosters.”
The tetanus antiserum is a blood product which contains antibodies directed against the tetanus toxin. Giving this confers passive immunity by introducing exogenously produced antibodies into the patient’s body. This protection is short lasting, though, as once the antibodies are cleared from the patient’s system, the body doesn’t “know” how to make more because it never learned how.
So why the two?
Patients who were never immunized or who haven’t gotten a recent booster are given the antiserum in addition to the vaccine. Since these patient’s immune systems haven’t been sensitized, the vaccine will produce a primary immune response, which is too slow to be protective. The passive immunization given by the antiserum works almost immediately, so it will protect the patient from the toxin’s effects. Giving them the vaccine is done as a preventative measure for future exposures.
Patients who are current with their immunizations are given a booster, which will cause their sensitized immune systems to create a secondary immune response (which is much faster than the primary response) and elevate the antibody levels before the toxin has caused any major damage.
On another note, the only disease that I’m aware of where the vaccine is routinely given after infection is rabies. That is made possible because the rabies infection progresses very slowly.
As for the OP, the approach here seems to be to stimulate the response of cytotoxic cells, which are immune cells that function by killing infected cells. It’s an interesting approach, as the AIDS virus can hide in human cells by integrating itself into our DNA. In theory, cytotoxic cells could kill off these infected cells. I would think for this to work, one would need to be vaccinated prior to exposure, as the idea would be to help the immune system prevent the infection from taking hold in the body (also, AIDS degrades your immune response so vaccines may not work properly), but the article is vague about the actual method, making most of this paragraph a semi-WAG.